A Montana man has been sentenced to six months in prison for illegally cloning and breeding giant sheep. His operation spanned Texas and Minnesota, where hybrid sheep were used in captive trophy hunts.

Swiss National Bank recently reduced its holding in Rhythm Pharmaceuticals by a modest 900 shares during the first quarter, as disclosed in a new SEC filing. Despite the small adjustment, the bank retains a significant position in the company.

PNC Financial Services Group has quietly pared back its stake in Vericel Corporation. A recent SEC filing shows the bank sold 378 shares in the first quarter—an 8.2 percent trim that leaves it holding 4,251 shares of the NASDAQ-listed biotech firm.

Zacks Small Cap has inched its third-quarter 2025 earnings forecast for Longeveron Inc. higher, trimming the biotech’s expected loss to 26 cents a share. The research note, issued Aug. 14 by analyst B. Sorensen, offers a modest but notable vote of confidence in the Nasdaq-listed company.

William Blair has lowered its third-quarter 2025 earnings forecast for Jasper Therapeutics to a loss of $0.75 per share, according to an analyst note issued on August 14. The deeper-than-expected projection, reported by Defenseworld.net, signals mounting challenges for the California-based biotech firm.

A new study reveals that Naloxone, the life-saving drug used to treat opioid overdoses, binds more to opioid receptors in women’s brains than in men’s. This finding suggests that sex differences may affect the efficacy of overdose treatments.

NASA is set to revolutionize Mars exploration with the Skyfall mission, deploying six helicopters from a flying mothership to advance autonomous aerial exploration. This bold initiative aims to pave the way for humanity’s first footsteps on the Red Planet.

Skin allergies are common and often frustrating to diagnose. But new technology could soon help change that. Emerging advances, including artificial intelligence, promise a more efficient future in allergy testing.

In a leap forward for robotics, the Walker S2 humanoid robot can now swap its own battery in just three minutes, challenging the autonomy of Tesla’s Optimus. This advancement marks the transition of battery swap technology from electric vehicles to the realm of industrial robotics.

Veteran pharmaceutical leader Don DeGolyer, former CEO of Sandoz Inc., has co-founded Ategenos, a PharmaTech startup preparing for its public launch. The company aims to tackle the global crisis of medication non-adherence, a problem costing $1 trillion worldwide.

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against RxSight, Inc., claiming that top executives made false and misleading statements in violation of federal securities laws. Investors who suffered substantial losses are encouraged to join the lawsuit before the September 22, 2025 deadline.

Xeltis has announced positive preliminary data from its ongoing EU clinical trial of the Xabg coronary artery bypass conduit. The study evaluates the technology in patients with multi-vessel coronary artery disease scheduled for elective bypass surgery.

Merck’s stock encounters significant hurdles as it approaches the Keytruda patent cliff and grapples with challenges related to Gardasil. A recent SWOT analysis reveals potential vulnerabilities that could impact the pharmaceutical giant’s financial outlook.

New research uncovers how prophages prevent superinfection by blocking bacterial cell surface receptors, ensuring the survival of their viral progeny.

In a groundbreaking move, the MLB All-Star Game introduced “robot umpires,” offering fans a firsthand look at the future of baseball officiating. The integration of this technology marks a significant step in how the game may be played and judged in years to come.

Swedish biopharmaceutical company Sobi has announced a strong second quarter for 2025, with total revenue increasing by 13%. The growth is propelled by significant gains in both its haematology and immunology portfolios. Despite incurring restructuring costs, the company achieved an improved adjusted EBITA margin, reflecting enhanced operational efficiency.

HSBC analysts are expressing skepticism about the profitability of robotaxis, cautioning that hidden costs could delay returns for years. Despite the rapid development by companies like Tesla and Waymo, the market for driverless taxis may be widely overestimated.

Researchers have discovered a novel way to retrain neutrophils—the body’s first responders—to directly attack aggressive breast cancer cells, offering new hope to patients unresponsive to current immunotherapies.

A self-driving lab is turning the tide in material discovery, collecting data ten times faster and paving the way for rapid scientific breakthroughs.

Just a week before groundbreaking HIV vaccine trials were set to begin, South African scientists received an email halting their efforts—aid cuts had struck a devastating blow to critical research.

The chair of Solvonis is set to participate in a biotech leadership panel, highlighting the company’s involvement in industry advancements.

Tesla is set to face its first jury trial over its autopilot system in a Miami federal court on Monday, a case that could significantly impact the company’s self-driving technology and reputation.

As one of 95 publicly-traded companies in the Medical Services industry, Bausch + Lomb faces a competitive landscape. This analysis examines how the company compares to its peers based on key financial metrics, including institutional ownership, profitability, earnings, risk, dividends, valuation, and analyst recommendations.

Houston Pest Management has launched a groundbreaking eco-friendly pest control system that promises rapid elimination of infestations within days. Combining biological agents with advanced digital monitoring, this innovation offers a safer alternative to traditional chemical treatments, addressing environmental and health concerns.

Filmmaker Peter Jackson is turning his passion for New Zealand’s natural history into action by partnering with biotech experts to attempt the revival of the extinct moa bird. His unique collaboration aims to bring back the flightless giant that once roamed his homeland.

Quest Diagnostics is set to offer an FDA-cleared blood test for Alzheimer’s disease developed by Fujirebio. Building on its pioneering AD-Detect™ product line, the test will be available for clinical and research use as soon as this summer, marking a significant advancement in assessing symptomatic patients.

While household names dominate the tech sector, some under-the-radar companies offer tremendous growth potential. Discover ten tech stocks that could be magnificent investments despite not being in the spotlight.

RxSight Inc. witnessed a dramatic 34% drop in after-hours trading after announcing revisions to its 2025 revenue forecast, sparking concerns among investors. The company’s stock closed at $8.40, down from $12.79, highlighting the market’s reaction to the updated financial outlook.

In a groundbreaking preclinical study, NurExone Biologic Inc.’s ExoPTEN treatment enabled 100% of animals in the high-dose group to regain motor function after spinal cord injury. The dose-dependent study offers renewed hope for future therapies, with significant improvements confirmed using advanced gait analysis technology.

In a landmark move, the Chan Zuckerberg Initiative and the Innovative Genomics Institute have announced a new center dedicated to bringing personalized CRISPR cures to children with rare genetic diseases.

Macquarie has downgraded Dr. Reddy’s Laboratories to a Neutral rating due to concerns over gRevlimid. This shift signals potential challenges ahead for the pharmaceutical company and could influence investor decisions.

Nauticus Robotics has announced a robust second quarter, driven by multiple new client projects that underscore its growing influence in the robotics sector. The company’s impressive performance highlights significant momentum within the industry.

Investor Gary Black anticipates that Tesla’s second-quarter deliveries will fall short of Wall Street estimates, suggesting that low expectations could make the release a ‘buy the news’ event. As attention shifts to Tesla’s Robotaxi ambitions in Austin, delivery numbers may become less significant to investors.

Time is running out to save hundreds on top-brand cordless vacuums. With up to 43% off Dyson, Samsung, Shark, and Roborock models, these expert-tested picks are the best deals before the EOFY ends.

In 2025, countries like the US, New Zealand, and Spain are pioneering new travel technologies, from AI-powered booking assistants to sustainable aviation. These innovations are enhancing convenience, personalization, and sustainability in the travel industry.

Elon Musk has announced that Tesla has delivered its first car fully autonomously from the factory to a customer’s home. While this could mark a significant leap in autonomous driving, questions remain about the system’s practicality and value.

A groundbreaking study from Dana-Farber Cancer Institute reveals that combining chemotherapy and immunotherapy before surgery can shrink aggressive stage III lung tumors, making surgery possible for patients previously deemed inoperable.

Cyngn’s stock soared by an astonishing 135% following the announcement of its partnership with Nvidia to showcase autonomous industrial vehicles at Automatica 2025. The collaboration marks a significant milestone in the autonomous vehicle industry.

Zymo Research made headlines at ASM Microbe 2025 with the unveiling of the MultiOmiX Workstation, a platform set to revolutionize microbiome workflows.

Liminatus Pharma is set to advance IBA101, a next-generation CD47 inhibitor designed to avoid the severe side effects that halted previous therapies, into human trials in the U.S. and Korea by early 2027. This innovative drug promises to redefine cancer immunotherapy by targeting tumors while sparing healthy cells, potentially offering new hope to patients.

The Global Mobile Scan Radiology Room Market is projected to grow significantly, expanding from USD 6.52 billion in 2025 to USD 10.73 billion by 2034. With a Compound Annual Growth Rate (CAGR) of 7.4%, the industry is poised for robust development driven by key growth factors.

Tesla’s recent launch of its robotaxi service in Austin has sent stock prices soaring, even as incidents caught on camera draw regulatory attention. Elon Musk is betting big on autonomous cabs to revitalize the company amid previous sales slumps.

Veho’s recent trial of RIVR’s wheel-legged delivery robots in Texas achieved a remarkable 95% success rate with minimal human intervention, according to CTO Fred Cook. This milestone signals a significant advancement in autonomous delivery technology.

Scientists in Pune are working diligently to isolate the COVID-19 sub-variants responsible for India’s recent spike in cases. This crucial step aims to assess the effectiveness of existing vaccines and determine whether new vaccines are needed, according to Dr. Naveen Kumar of the National Institute of Virology.

Elanco’s innovative treatment for canine allergies, Zenrelia, has received a positive opinion from European Union regulators. This milestone marks significant progress in addressing pet health concerns across Europe.

Jonathan Jones, a seventh grader from Minnesota, experienced the wonder of color for the first time after his principal, who is also colorblind, lent him special glasses. The emotional moment highlights the profound impact of empathy and innovation in changing lives.

Tesla’s long-awaited robotaxi service is tentatively scheduled to launch in Austin, Texas, on June 22, 2025, according to CEO Elon Musk. The company is placing a strong emphasis on safety, which may affect the actual timing of the rollout.

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II clinical trial to evaluate the efficacy of Zoryve (roflumilast) cream 0.05% for treating atopic dermatitis in infants. The INTEGUMENT-INFANT trial represents a significant step toward addressing a prevalent inflammatory skin condition among young children.

Elon Musk has revealed that Tesla is tentatively set to launch its robotaxi service in Austin, Texas, on June 22. This potential rollout marks a significant advancement in autonomous transportation for the company.

Facing invasive breast cancer, Kate Rouch, Chief Marketing Officer at OpenAI, turned to ChatGPT to navigate her treatment. Her journey illuminates the personal impact of AI technology in healthcare and offers a unique perspective from a leader in the tech industry.

As fertility issues rise globally, the traditional American Dream becomes less attainable for many. AMS is building global trust through science-backed supplements, aiming to redefine reproductive wellness and offer hope to those affected.

The American Society for Gravitational and Space Research is now accepting abstracts for its 2025 conference in Phoenix. From December 3-6, scientists and engineers from all career stages will gather to share research, build collaborations, and discuss emerging issues in space science.

A new report from Exactitude Consultancy predicts that the molecular targeted therapy market will surpass $246 billion by 2034, marking significant growth in the healthcare sector.

A pioneering fragrance company is on a mission to revive the scents of flowers that have vanished from our world, offering a sensory journey back in time.

Faricimab has demonstrated greater fluid reduction than high-dose aflibercept at 12 weeks, offering new hope for patients with diabetic macular edema and age-related macular degeneration. These findings could influence future treatment approaches for these common eye conditions.

NASA strategically divides its life science research into Space Biology and Astrobiology, fostering collaboration between life scientists and physical scientists. This approach aims to understand how biological systems acclimate, adapt, and evolve in space, advancing NASA’s life science objectives.

In a surprising move, the Trump administration has canceled a $766 million contract with Moderna Inc. aimed at developing vaccines against potential pandemic flu strains, including the deadly H5N1 bird flu.

NASA’s Mars Perseverance rover snapped a selfie as a Martian dust devil blew by, capturing a unique moment on the Red Planet. The rover’s photo offers a rare glimpse into the Martian environment.

Biomedical engineers at Georgia Tech have developed an experimental treatment that trains the immune system to recognize and eliminate hard-to-treat cancers. The approach showed success in lab tests without harming healthy tissues and prevented cancer from returning.

Cantor Fitzgerald has reaffirmed its ‘overweight’ rating on Capricor Therapeutics (NASDAQ: CAPR). The brokerage set a $30 price target and estimated FY2025 earnings at $1.71 per share.

A driverless truck’s delivery in Dallas isn’t just a technological milestone—it’s a signal of the profound changes stirring within Texas politics that could reshape the nation. Sometimes, the smallest events herald the biggest transformations.

With over 48 million Americans affected by hearing loss, Audien’s over-the-counter hearing aids are reshaping accessibility and affordability in a once prohibitive market. By eliminating traditional barriers like high costs and prescriptions, Audien offers discreet, advanced solutions that empower users to reconnect with the world around them.

A Russian research associate at Harvard University has been detained since February after being charged with smuggling frog embryos into the United States. Facing possible deportation, her lawyer disputes the allegations as “meritless.”

ADAMA Ltd. has announced U.S. registration for Temper More, a new herbicide offering a powerful defense against herbicide-resistant weeds in row crops.

Lenovo has introduced a new humanoid robot in China capable of performing Tai Chi, symbolizing a remarkable blend of technology and tradition. Dubbed a potential ‘silicon employee’, this innovation could signify a transformative step in robotics and the future workforce.

Ukrainian tech professionals worldwide are leveraging their expertise to bolster their nation’s defense, signaling a technological uprising amid conflict. As Ukraine faces unprecedented challenges, its well-established tech community steps up, potentially paving the way for Europe’s next Silicon Valley.

The CEO of Travere Therapeutics has recently sold $398,000 worth of company stock, according to a report by Investing Us. This significant insider transaction highlights executive activity within the company.

Cuprina Holdings, a biomedical company specializing in chronic wound management and cosmeceuticals, has announced the pricing of its initial public offering at $4.00 per share. The firm commitment offering includes 3,000,000 Class A Ordinary Shares, aiming to raise $12 million.

Vertex Pharmaceuticals is poised to announce its first-quarter earnings for 2025 after the market closes on Monday, May 5th. Analysts project robust financial results, anticipating earnings of $4.24 per share and revenue of $2.85 billion. The company has also set its fiscal year 2025 guidance at earnings per share.

Genmab announces plans to submit a supplemental Biologics License Application to the FDA for a combination therapy targeting relapsed or refractory follicular lymphoma, potentially offering new hope to patients.

Coloplast A/S has updated its financial guidance for the fiscal year 2024/25 and pre-announced key financial figures for the first half of the year. This significant move signals important developments for investors and stakeholders alike.

Bank of America Global Research forecasts that the mass adoption of humanoid robots will commence in 2028, potentially revolutionizing industries worldwide. By 2060, they predict an astounding three billion humanoid robots could be in ownership globally, marking a significant shift towards automation and technological integration.

A research team has unveiled a novel method for isolating high-purity muscle stem cells from pig tissue, a breakthrough that could enhance the production of cultured meat.

Algorized, a pioneering deep tech startup specializing in people-sensing AI, has joined the prestigious MassRobotics startup community. This partnership aims to redefine the future of human-machine interaction through advanced sensor fusion technology.

Promising advances in immunotherapy may allow some cancer patients to bypass chemotherapy, radiation, and surgery. New clinical trial findings reported by Dr. Jon LaPook suggest a groundbreaking shift in cancer treatment, offering renewed hope to many.

Photocure ASA presented new studies at the AUA2025 conference highlighting how Blue Light Cystoscopy (BLC) improves the detection and risk stratification of bladder cancer, aiding in more informed treatment decisions.

Microplastics have been discovered in the large neck arteries that supply blood to the brain, with stroke survivors showing the highest levels of accumulation, according to a recent small study.

CG Oncology, a small biotech firm rivaling Johnson & Johnson, saw its stock soar 44% following promising clinical trial results for its bladder cancer drug. The breakthrough has drawn significant investor attention and could signal a shift in cancer treatment options.

As one of 300 publicly-traded companies in its industry, Metagenomi (NASDAQ: MGX) faces stiff competition. We delve into how it measures up against its peers in key financial metrics.

The U.S. Transportation Department is taking steps to remove regulatory hurdles for automakers, aiming to foster innovation in autonomous vehicle technology and compete with China. This initiative seeks to accelerate development in the self-driving car industry by streamlining regulations that have previously hindered progress.

Actuate Therapeutics is set to present the topline results of its Phase 2 trial of elraglusib at the 2025 American Society of Clinical Oncology Annual Meeting. The oral presentation will focus on the combination of elraglusib with gemcitabine/nab-paclitaxel in the first-line treatment of metastatic pancreatic ductal adenocarcinoma.

Global agriculture faces mounting waste disposal challenges and the threat of antibiotic resistance. Mushroom-based composting emerges as a promising solution to improve waste degradation, reduce pathogens, and curb the spread of antibiotic resistance genes, safeguarding agricultural safety and the environment.

Robles BioCeutics has appointed renowned drug developer and healthcare entrepreneur Dr. Radu Pislariu to its Scientific Advisory Board. This strategic move comes as the company gears up for clinical trials in regenerative dermatology.

A rising number of dogs are silently suffering from gut health issues. WildGut introduces a groundbreaking fruit seed detox to address the root causes and restore canine vitality with a simple, once-a-day chew.

Hammer Missions, a London-based AI company specializing in drone inspections of built structures, has raised €1.6 million to accelerate its technology development and expand into North America.

Three teenagers have developed the Thermavault, a salt-powered refrigerator that operates without electricity. They’re set to build 200 units for hospitals, aiming to keep vaccines cool with a reusable salt solution.

Twenty exceptional Georgia Tech students have received NSF Graduate Research Fellowships, securing significant funding for their advanced studies in STEM fields. The fellowships, valued at $159,000 each, support three years of graduate study and tuition.

Duchesnay Pharmaceutical Group has established an Advisory Board comprising five external experts. This strategic move aims to leverage their diverse experience to guide the company’s continued growth and success.

The Native Plant Society is empowering the next generation of ecologists by awarding grants that support essential fieldwork and research. Students will not only advance their studies through activities like DNA sequencing and ecological monitoring but also enrich the community by sharing their findings.

In a surprising turn of events, researchers from Florida Atlantic University have accidentally documented a great white shark in an area where such sightings are rare, thanks to a nurse shark’s camera. This unexpected encounter could provide valuable insights into the behavior and distribution of these elusive predators.

With few effective treatments available for amyotrophic lateral sclerosis, the ashwagandha plant emerges as a beacon of hope for patients battling this debilitating disease. Could this ancient remedy provide relief where modern medicine has struggled?

Researchers have developed nerve grafts that can evade the immune system, dubbed an ‘invisibility cloak.’ These grafts are currently being trialed as a treatment for Parkinson’s disease, potentially revolutionizing therapies for neurodegenerative conditions.

Imagine harnessing the benefits of dreaming without closing your eyes. Scientists now suggest that certain psychedelics could make this a reality.

CERo Therapeutics has expanded its patent portfolio with new approvals in the United States, marking a significant milestone in the company’s growth. This strategic move strengthens its position in the biotechnology industry and underscores its commitment to innovation.

Trilobio introduced its comprehensive robotics lab equipment and software platform at the SLAS conference. Designed by biologists for biologists, the platform enables users to operate robots within 30 minutes of unboxing and design research protocols in minutes.

Rhythm Pharmaceuticals announces promising results from their Phase 3 TRANSCEND trial, where setmelanotide significantly reduced BMI in patients with acquired hypothalamic obesity. This breakthrough offers new hope for treating this rare condition resulting from hypothalamic damage.

Context Therapeutics has reported its fiscal year 2024 results, highlighting significant strides in cancer immunotherapy. With strategic acquisitions and a strengthened financial position, the biotech firm is poised to advance its pipeline of T cell engaging bispecific antibodies targeting solid tumors.

Northwestern University researchers have uncovered how specific structural features in engineered cell receptors influence their function. By utilizing advanced computational tools, they offer new insights that could revolutionize synthetic cell therapies.

Anbio Biotechnology, a global leader in in vitro diagnostics, has successfully closed its $8 million initial public offering, marking its debut on the Nasdaq Global Market under the ticker symbol “NNNN”. The company plans to utilize the funds to expand its global footprint, accelerate research and development, and advance its mission to transform the diagnostics industry.

Ignite Proteomics has completed the acquisition of PLA code 0249U for its advanced breast cancer assay, integrating laboratory capabilities and intellectual property. This milestone enhances the test’s recognition in billing systems, paving the way for wider adoption in precision oncology.

The manufacturing industry is grappling with persistent challenges, notably a growing skills gap. Could implementing AI be the key to expanding human potential and bridging this divide?

Jaguar has received regulatory clearance in Germany and Italy to conduct a study of Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF). This approval marks a significant advancement in rare disease research and offers potential hope for patients.

NAYA Biosciences has announced the nomination of new board members, marking a significant step in its corporate governance. Reported by Investing.com on February 19, 2025, this move highlights the company’s ongoing developments in the pharma and healthcare industry.

Illumina has announced a first-of-its-kind spatial transcriptomics technology, marking a significant advancement in the field. The unveiling positions the company at the forefront of technological innovation.

Moderna has reported a decline in its revenue for the fourth quarter of 2024, according to a recent publication by Yahoo Finance. The report highlights a shift in the company’s financial performance during this period.

As healthcare professionals grapple with an overwhelming influx of data, AI-generated summaries are emerging as crucial tools to streamline workflows and enhance patient care. While promising significant efficiency gains, ensuring the accuracy and trustworthiness of these summaries remains a critical challenge.

From C-3PO to Wall-E, friendly robots have captured our imaginations and our hearts on the big screen. These films showcase robots that prove machines can have heart, offering an optimistic view of technology’s potential.

Hohem has unveiled the iSteady M7, an AI-powered gimbal that turns smartphones into professional filming tools. With advanced subject tracking, a detachable touchscreen controller, and extended battery life, the iSteady M7 offers content creators a versatile and powerful stabilization solution.

From significant corporate expansions to generous community contributions, businesses in Hampton Roads are propelling economic growth and fostering community development. Recent initiatives highlight a strong commitment to innovation, philanthropy, and leadership in the region.

A new innovation in skincare introduces single-use face towels designed to promote clearer skin and reduce irritation. Made from eco-friendly materials, these towels offer a hygienic alternative to traditional cloth towels.

Scientists at the University of Exeter have developed a new algorithm to interpret standard blood tests more effectively, potentially helping general practitioners detect cancer warning signs sooner. The Royal Devon University Healthcare NHS Foundation Trust is the first to implement this method, which considers age and sex variations in platelet counts to flag patients who may need further investigation.

The global autonomous vehicle market is accelerating rapidly, projected to expand from $46.3 billion in 2023 to over $300 billion by 2033. Technological advancements and a growing emphasis on commercial applications are steering this unprecedented growth.

SpaceX’s Falcon 9 rocket has successfully launched two lunar landers, Firefly Space’s Blue Ghost and ispace’s Resilience, from NASA’s Kennedy Space Center. This mission marks a significant step toward returning humans to the Moon, as part of NASA’s Artemis program scheduled for 2026.

In a groundbreaking launch, SpaceX has sent Japanese and U.S. lunar landers on separate missions to the Moon, marking a significant advancement in the race to commercialize Earth’s lunar neighbor. The missions by ispace and Firefly Aerospace aim to establish a business presence on the Moon and pave the way for future exploration.

In a groundbreaking move to accelerate global biomedical discoveries, the Broad Institute of MIT and Harvard has announced a strategic collaboration with Manifold. Together, they aim to develop an AI-enabled research platform that promises to remove technical barriers and transform life sciences research.

AEKE’s K1 smart gym has shattered crowdfunding expectations, raising over $1 million and setting a new standard for home fitness technology. With its innovative AI features and plans for global expansion, the AEKE K1 is poised to revolutionize how we work out at home. The company’s commitment to user-centric design promises a personalized fitness experience without monthly subscriptions.

At CES 2025 in Las Vegas, LG Innotek captivated 65,000 visitors with its innovative mobility components. Through a ‘User-Centric storytelling’ approach, the company received strong acclaim and customer inquiries, reaffirming its leadership in the future mobility market.

Fermata, an Israeli agtech company, has raised $10 million in Series A funding to develop AI-driven solutions for the horticulture industry. The funding, backed by Raw Ventures, will support the creation of a centralized digital brain for autonomous crop management.

RazorMetrics has launched an AI-driven Polypharmacy Solution aimed at reducing medication overload affecting nearly a quarter of U.S. adults, optimizing patient safety and lowering healthcare costs.

Illumina and NVIDIA have announced a groundbreaking collaboration to advance multiomic data analysis, promising to accelerate drug discovery and precision health. By integrating Illumina’s sequencing technologies with NVIDIA’s AI tools, the partnership aims to revolutionize the analysis and interpretation of genomic data.

A new study reveals that Kognitic’s AI neural network model dramatically improves the accuracy of clinical trial completion predictions, reducing errors from 508 to 179 days. This advancement promises significant cost savings for pharmaceutical companies facing costly delays.

Shares of Moderna tumbled sharply on Monday after the vaccine maker projected a larger-than-anticipated drop in sales for 2025. The unexpected forecast surprised analysts and investors, signaling potential challenges ahead for the biotech firm.

Applied Therapeutics is under fire as investors file a class action lawsuit following the FDA’s refusal to approve its lead drug, causing stock prices to plummet over 80%. Investors have until February 18, 2025, to join the lawsuit alleging securities fraud.

Kyverna Therapeutics faces a class action lawsuit alleging the company made false statements and concealed critical information during its February 2024 IPO. Investors who purchased stock may be eligible to join the lawsuit led by Levi & Korsinsky, LLP.

Investors in Humacyte, Inc. have filed a class action lawsuit alleging securities fraud against the company. The suit claims that Humacyte concealed critical manufacturing deficiencies, leading to investor losses. Affected shareholders have until January 17, 2025, to seek lead plaintiff status.

Investors in Dentsply Sirona Inc. are being notified of a class action lawsuit alleging securities fraud related to the company’s Byte aligners. The lawsuit claims that Dentsply concealed severe patient injuries and failed to report them to the FDA, potentially misleading investors about the company’s financial health.

Cassava Sciences is facing a class-action lawsuit following the failure of its Alzheimer’s drug candidate, simufilam, in Phase 3 trials. Investors allege securities fraud after the company’s stock plummeted by over 80% in a single day.

Biotech firm Immunic, Inc. announced significant progress in developing treatments for multiple sclerosis, with upcoming trial results and strengthened leadership bolstering their efforts. The company’s lead drug, vidofludimus calcium, shows promise in both relapsing and progressive forms of the disease.

The global smart mining market is projected to exceed $40.5 billion by 2032, driven by the integration of advanced technologies that enhance operational efficiency and safety. Environmental regulations and investments in tech startups are accelerating the adoption of smart solutions in the mining industry.

At CES 2025, Samsung announced that Ballie, its AI-powered rolling robot, will be available to consumers in the first half of the year. With voice recognition and projection capabilities, Ballie aims to redefine the smart home experience.

Zomedica Corp. has announced an exclusive agreement to market Cresilon’s revolutionary Vetigel® hemostatic gel in the U.S., marking a significant expansion of its veterinary health portfolio.

Liam Kelly, Chairman, President, and CEO of Teleflex Incorporated, is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. The presentation will be available via live audio webcast on the Teleflex investor website, offering insights into the company’s mission to improve global health.

SpringWorks Therapeutics’ CEO, Saqib Islam, is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025. The announcement follows the company’s recent FDA approval of their first therapy, OGSIVEO®, marking a significant milestone in their mission to treat severe rare diseases and cancer.

As Chinese-made drones dominate U.S. skies, Congress moves to halt new sales, citing espionage fears and a struggling domestic industry. This legislative push reflects the growing technological rivalry between the United States and China.

Despite advanced software, harmful medication errors persist with current infusion pumps. The innovative Ivenix system aims to change that by enhancing drug delivery efficiency and patient safety.